66 related articles for article (PubMed ID: 30604502)
21. Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer.
Zeng Z; Li D; Yu T; Huang Y; Yan H; Gu L; Yuan J
Oncol Lett; 2019 Jan; 17(1):1128-1138. PubMed ID: 30655874
[TBL] [Abstract][Full Text] [Related]
22. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
Zhu H; Yan F; Yuan T; Qian M; Zhou T; Dai X; Cao J; Ying M; Dong X; He Q; Yang B
Cancer Res; 2020 Jun; 80(11):2204-2216. PubMed ID: 32217697
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the deubiquitinase USP10 induces degradation of SYK.
Yang J; Meng C; Weisberg E; Case A; Lamberto I; Magin RS; Adamia S; Wang J; Gray N; Liu S; Stone R; Sattler M; Buhrlage S; Griffin JD
Br J Cancer; 2020 Apr; 122(8):1175-1184. PubMed ID: 32015510
[TBL] [Abstract][Full Text] [Related]
24. Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia.
Minuesa G; Albanese SK; Xie W; Kazansky Y; Worroll D; Chow A; Schurer A; Park SM; Rotsides CZ; Taggart J; Rizzi A; Naden LN; Chou T; Gourkanti S; Cappel D; Passarelli MC; Fairchild L; Adura C; Glickman JF; Schulman J; Famulare C; Patel M; Eibl JK; Ross GM; Bhattacharya S; Tan DS; Leslie CS; Beuming T; Patel DJ; Goldgur Y; Chodera JD; Kharas MG
Nat Commun; 2019 Jun; 10(1):2691. PubMed ID: 31217428
[TBL] [Abstract][Full Text] [Related]
25. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review.
Al-Balushi E; Al Marzouqi A; Tavoosi S; Baghsheikhi AH; Sadri A; Aliabadi LS; Salarabedi MM; Rahman SA; Al-Yateem N; Jarrahi AM; Halimi A; Ahmadvand M; Abdel-Rahman WM
World J Gastrointest Oncol; 2024 Jan; 16(1):197-213. PubMed ID: 38292842
[TBL] [Abstract][Full Text] [Related]
27. Musashi-2 Deficiency Triggers Colorectal Cancer Ferroptosis by Downregulating the MAPK Signaling Cascade to Inhibit HSPB1 Phosphorylation.
Meng X; Peng X; Ouyang W; Li H; Na R; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Zhuang G; Tang H; Peng Z
Biol Proced Online; 2023 Dec; 25(1):32. PubMed ID: 38041016
[TBL] [Abstract][Full Text] [Related]
28. CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis.
Tang Z; Xu Y; Tan Y; Shi H; Jin P; Li Y; Teng J; Liu H; Pan H; Hu Q; Cheng X; Ye J; Su Y; Sun Y; Meng J; Zhou Z; Chi H; Wang X; Liu J; Lu Y; Liu F; Dai J; Yang C; Chen S; Liu T
Nat Commun; 2023 Aug; 14(1):5077. PubMed ID: 37604832
[TBL] [Abstract][Full Text] [Related]
29. Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer.
Yang YC; Zhao CJ; Jin ZF; Zheng J; Ma LT
Front Oncol; 2023; 13():1120828. PubMed ID: 36969062
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response.
Ye Z; Chen J; Huang P; Xuan Z; Zheng S
Front Oncol; 2022; 12():990195. PubMed ID: 36248971
[TBL] [Abstract][Full Text] [Related]
31. Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis.
Liu J; Leung CT; Liang L; Wang Y; Chen J; Lai KP; Tse WKF
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884607
[TBL] [Abstract][Full Text] [Related]
32. CircCOL1A2 Sponges MiR-1286 to Promote Cell Invasion and Migration of Gastric Cancer by Elevating Expression of USP10 to Downregulate RFC2 Ubiquitination Level.
Li H; Chai L; Ding Z; He H
J Microbiol Biotechnol; 2022 Jul; 32(7):938-948. PubMed ID: 35791074
[TBL] [Abstract][Full Text] [Related]
33. USP10 as a Potential Therapeutic Target in Human Cancers.
Tao L; Liu X; Jiang X; Zhang K; Wang Y; Li X; Jiang S; Han T
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627217
[TBL] [Abstract][Full Text] [Related]
34. The emerging role of ubiquitin-specific protease 20 in tumorigenesis and cancer therapeutics.
Li Q; Ye C; Tian T; Jiang Q; Zhao P; Wang X; Liu F; Shan J; Ruan J
Cell Death Dis; 2022 May; 13(5):434. PubMed ID: 35508480
[TBL] [Abstract][Full Text] [Related]
35. [Advances in research of Musashi2 in solid tumors].
Yang Y; Zhao M; Ding T; Ni C; Zheng Q; Li X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):448-456. PubMed ID: 35426812
[TBL] [Abstract][Full Text] [Related]
36. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.
Zhu Y; Zhou B; Hu X; Ying S; Zhou Q; Xu W; Feng L; Hou T; Wang X; Zhu L; Jin H
Clin Transl Med; 2022 Jan; 12(1):e703. PubMed ID: 35073459
[TBL] [Abstract][Full Text] [Related]
37. Implications of the USP10-HDAC6 axis in lung cancer - A path to precision medicine.
Zhang XM; Gavande N; Parajuli P; Bepler G
J Cancer Biol; 2021; 2(1):. PubMed ID: 34746935
[TBL] [Abstract][Full Text] [Related]
38. Potential Role of Musashi-2 RNA-Binding Protein in Cancer EMT.
Sun J; Sheng W; Ma Y; Dong M
Onco Targets Ther; 2021; 14():1969-1980. PubMed ID: 33762829
[TBL] [Abstract][Full Text] [Related]
39. RNA-Binding Protein MSI2 Binds to miR-301a-3p and Facilitates Its Distribution in Mitochondria of Endothelial Cells.
Guo QQ; Gao J; Wang XW; Yin XL; Zhang SC; Li X; Chi LL; Zhou XM; Wang Z; Zhang QY
Front Mol Biosci; 2020; 7():609828. PubMed ID: 33553241
[TBL] [Abstract][Full Text] [Related]
40. Integrated analysis of RNA-binding proteins in human colorectal cancer.
Fan X; Liu L; Shi Y; Guo F; Wang H; Zhao X; Zhong D; Li G
World J Surg Oncol; 2020 Aug; 18(1):222. PubMed ID: 32828126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
